122 related articles for article (PubMed ID: 38511912)
1. The Effect of a Required 48-Hour Window to Schedule Genetic Counseling on Time From Diagnosis of Breast Cancer to Surgery.
Hobbs K; Wheeler P; Campbell S; Workman C; Monroe M; Davies C
Clin J Oncol Nurs; 2024 Mar; 28(2):157-16. PubMed ID: 38511912
[TBL] [Abstract][Full Text] [Related]
2. Increasing utilization of cancer genetic counseling services using a patient navigator model.
Rahm AK; Sukhanova A; Ellis J; Mouchawar J
J Genet Couns; 2007 Apr; 16(2):171-7. PubMed ID: 17277995
[TBL] [Abstract][Full Text] [Related]
3. What happens after referral? Completion rates of genetic counseling evaluations in breast cancer patients.
Ochoa D; Jean-Louis C; Stephenson K; Woods M; Kelsey J; Henry-Tillman R
J Natl Med Assoc; 2022 Feb; 114(1):90-93. PubMed ID: 35039176
[TBL] [Abstract][Full Text] [Related]
4. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
[TBL] [Abstract][Full Text] [Related]
5. Uptake of genetic counseling and testing in a clinic-based population of women with breast cancer.
Wehbe A; Manning M; Assad H; Purrington KS; Simon MS
Cancer Med; 2022 Sep; 11(17):3304-3311. PubMed ID: 35322585
[TBL] [Abstract][Full Text] [Related]
6. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
[TBL] [Abstract][Full Text] [Related]
7. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
[TBL] [Abstract][Full Text] [Related]
8. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
[TBL] [Abstract][Full Text] [Related]
9. Increase in Genetic Counseling and Testing Referrals After Breast Cancer Pathway Implementation.
Graff SL; Holder JM; Sears LE; Kurbegov D
JCO Oncol Pract; 2020 Dec; 16(12):e1481-e1488. PubMed ID: 32650693
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis.
Kritzik R; Usoro E; Peshkin BN; Isaacs C; Valdimarsdottir HB; Willey S; O'Neill S; DeMarco T; Nusbaum R; Jandorf L; Kelleher S; Schwartz MD
Psychooncology; 2022 May; 31(5):788-797. PubMed ID: 34921700
[TBL] [Abstract][Full Text] [Related]
11. Impact of an embedded genetic counselor on breast cancer treatment.
Pederson HJ; Hussain N; Noss R; Yanda C; O'Rourke C; Eng C; Grobmyer SR
Breast Cancer Res Treat; 2018 May; 169(1):43-46. PubMed ID: 29349711
[TBL] [Abstract][Full Text] [Related]
12. The impact of nurse navigation on timeliness to treatment for benign high-risk breast pathology.
Barker CS; Chung CW; Mukherjee R; Siegel JB; Cole DJ; Lockett MA; Klauber-DeMore N; Abbott AM
Breast Cancer Res Treat; 2023 Nov; 202(1):129-137. PubMed ID: 37584883
[TBL] [Abstract][Full Text] [Related]
13. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
[TBL] [Abstract][Full Text] [Related]
14. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
15. Universal access to genetic counseling for women with epithelial ovarian cancer in Nova Scotia: Evaluating a new collaborative care model.
Warias A; Ferguson M; Chamberlain E; Currie L; Snow N; Matheson K; Penney LS; Kieser K
J Genet Couns; 2021 Oct; 30(5):1491-1499. PubMed ID: 33876505
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the process and content of genetic counseling in familial breast cancer consultations.
Butow PN; Lobb EA
J Genet Couns; 2004 Oct; 13(5):403-24. PubMed ID: 15604639
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms to increase cascade testing in hereditary breast and ovarian cancer: Impact of introducing standardized communication aids into genetic counseling.
Garcia C; Sullivan MW; Lothamer H; Harrison KM; Chatfield L; Thomas MH; Modesitt SC
J Obstet Gynaecol Res; 2020 Sep; 46(9):1835-1841. PubMed ID: 32656916
[TBL] [Abstract][Full Text] [Related]
18. Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.
Pasick RJ; Joseph G; Stewart S; Kaplan C; Lee R; Luce J; Davis S; Marquez T; Nguyen T; Guerra C
Am J Public Health; 2016 Oct; 106(10):1842-8. PubMed ID: 27552275
[TBL] [Abstract][Full Text] [Related]
19. Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling?
Zilliacus EM; Meiser B; Lobb EA; Kelly PJ; Barlow-Stewart K; Kirk JA; Spigelman AD; Warwick LJ; Tucker KM
Genet Med; 2011 Nov; 13(11):933-41. PubMed ID: 21799430
[TBL] [Abstract][Full Text] [Related]
20. Is genetic counseling a stressful event?
Nordin K; Roshanai A; Bjorvatn C; Wollf K; Mikkelsen EM; Bjelland I; Kvale G
Acta Oncol; 2011 Oct; 50(7):1089-97. PubMed ID: 21864049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
